查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1771662

美國高級創傷護理OTC 市場規模、佔有率、趨勢分析報告：按產品、應用、分銷管道和細分市場預測，2025-2033 年

U.S. Advanced Wound Care OTC Market Size, Share & Trends Analysis Report By Product, By Application, By Distribution Channel, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

美國非處方高級創傷護理市場摘要

預計 2024 年美國先進創傷護理OTC 市場規模為 27.7 億美元，到 2033 年將達到 66.1 億美元，2025 年至 2033 年的複合年成長率為 10.33%。成長的動力來自於急性傷口的增加，包括外科性創傷、創傷傷口和燒燙傷，這些傷口需要有效、快速的傷口管理解決方案。

在全球範圍內，交通事故、運動傷害和外科手術的增多，推動了對能夠加速傷口癒合並降低感染風險的先進非處方創傷護理產品的需求激增。根據全家護理中心（Total Family Care Center）2025年4月發布的數據，美國每年約有1,100萬人遭遇急性傷口，其中約30萬人需要住院治療。此外，消費者對正確創傷護理實務的認知不斷提高，以及透過零售藥局和線上平台輕鬆取得先進敷料，也持續支撐著市場擴張。

美國糖尿病盛行率高且持續上升，是市場成長的主要驅動力。糖尿病是導致慢性傷口（尤其是糖尿病足潰瘍）的重要風險因素，及時有效的傷口管理對於預防感染疾病和截肢等併發症至關重要。例如，根據美國疾病管制與預防美國(CDC) 的報告，超過 3,800 萬美國人患有糖尿病（約占美國人口的十分之一），其中約 90% 至 95% 患有第 2 型糖尿病。

人們對易於取得的非處方創傷護理產品的需求日益成長，這些產品能夠有效管理輕微傷口並防止其惡化。先進的非處方創傷護理產品為糖尿病患者提供了一種便捷的居家傷口護理方式，減少了頻繁就醫的需求。糖尿病患者日益成長的自我護理需求，推動了美國先進創傷護理非處方藥產業的擴張。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章美國高階創傷護理OTC市場變數、趨勢與範圍

  • 市場展望
    • 母市場展望
    • 補貼市場前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
    • 市場機會分析
    • 市場問題分析
  • 美國先進創傷護理OTC市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章美國高階創傷護理OTC市場：產品評估與趨勢分析

  • 細分儀表板
  • 美國先進創傷護理OTC市場波動分析
  • 美國高級創傷護理OTC 市場規模和趨勢分析（按產品，2021-2033 年）
  • 泡棉敷料
    • 膠水
    • 非黏性泡棉敷料
  • 膜敷料
  • 親水膠體
  • 水凝膠敷料
  • 蜂蜜醬
  • 油性紗布
  • 不織布術後敷料
  • 其他

第5章美國高階創傷護理OTC市場：應用評估與趨勢分析

  • 細分儀表板
  • 美國先進創傷護理OTC市場波動分析
  • 2021 年至 2033 年美國高階創傷護理OTC 市場規模及應用趨勢分析
  • 慢性傷口
    • 糖尿病足潰瘍（1期、2期、3期、4期、深層組織損傷）
    • 壓瘡
    • 靜脈性腿部潰瘍
    • 其他慢性傷口
  • 急性傷口
    • 外科性創傷和外傷（包括皮膚撕裂）
    • 燒燙傷

第6章美國高階創傷護理OTC市場：通路評估與趨勢分析

  • 細分儀表板
  • 美國先進創傷護理OTC市場波動分析
  • 美國高級創傷護理OTC 市場規模及趨勢分析（按分銷管道），2021 年至 2033 年
  • 零售藥局/藥局
  • 電子商務/網路藥局/健康相關電子商務
  • 其他

第7章 競爭態勢

  • 市場參與企業分類
  • 主要企業簡介
  • Company Share Analysis, 2024
    • 史密斯侄子
    • 溶劑
    • Mölnlycke Healthcare AB
    • 3M
    • 康維泰克公司
    • 餛飩
    • Vomaris Innovations公司
    • B. 布朗 SE
    • 康樂保集團
    • 保羅哈特曼股份公司
    • 拜爾斯道夫
    • 迪莫拉醫療
    • Remedy 保健產品
    • 索諾瑪製藥公司
    • 康德樂
    • 德羅亞爾工業公司
    • 梅德林工業公司
    • 餛飩
Product Code: GVR-4-68040-632-2

U.S. Advanced Wound Care OTC Market Summary

The U.S. advanced wound care OTC market size was estimated at USD 2.77 billion in 2024 and is projected to reach USD 6.61 billion by 2033, growing at a CAGR of 10.33% from 2025 to 2033. The growth is driven by the increasing prevalence of acute wounds, such as surgical wounds, traumatic injuries, and burns, which require effective and immediate wound management solutions.

Rising rates of road accidents, sports injuries, and surgical procedures globally have led to a surge in demand for advanced OTC wound care products that promote faster healing and reduce the risk of infection. According to the data published by the Total Family Care Center in April 2025, approximately 11 million individuals in the U.S. experience acute wounds annually, with around 300,000 cases requiring hospital care. In addition, the growing awareness among consumers regarding proper wound care practices and the ease of access to advanced dressings through retail pharmacies and online platforms continue to support market expansion.

The high and rising prevalence of diabetes in the U.S. significantly drives the growth of the market. Diabetes is a significant risk factor for the development of chronic wounds, particularly diabetic foot ulcers, which require timely and effective wound management to prevent complications such as infections and amputations. For instance, the Centers for Disease Control and Prevention (CDC) reports that more than 38 million Americans have diabetes (about 1 in 10), and about 90% to 95% of them have type 2 diabetes.

There is an increasing demand for accessible, over-the-counter wound care products that allow individuals to manage minor wounds and prevent them from worsening. Advanced OTC wound care solutions offer diabetic patients a convenient way to treat wounds at home, reducing the need for frequent clinical visits. This growing need for self-care solutions among the diabetic population is a key factor propelling the expansion of the U.S. advanced wound care OTC industry.

U.S. Advanced Wound Care OTC Market Report Segmentation

This report forecasts revenue growth at regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. advanced wound care OTC market report based on product, application, and distribution channel.

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Foam Dressings
    • Adhesive
    • Non-adhesive Foam Dressings
  • Film Dressings
  • Hydrocolloids
  • Hydrogel Dressings
  • Honey Dressings
  • Greasy Gauzes
  • Non-Woven Post Operative Dressings
  • Others
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Chronic Wounds
    • Diabetic Foot Ulcers
    • Pressure Ulcers (Stage 1, Stage 2, Stage 3, Stage 4, and Deep Tissue Injury included)
    • Venous Leg Ulcers
    • Other Chronic Wounds
  • Acute Wounds
    • Surgical & Traumatic Wounds (skin tears included)
    • Burns
    • 1st degree burns
    • 2nd degree burns
    • 3rd degree burns
  • Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
  • Retail Pharmacies / Drugstores
  • E-commerce/Online Pharmacies / Health E-tailers
  • Others

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Application
    • 1.2.3. Distribution Channel
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Advanced Wound Care OTC Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing adoption of digital distribution platforms
      • 3.2.1.2. Rising burden of wounds
      • 3.2.1.3. Increasing approvals for advanced wound care OTC products
      • 3.2.1.4. Rising aging population in the U.S.
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Product recalls
    • 3.2.3. Market Opportunities Analysis
      • 3.2.3.1. Shift from institutional settings to home care
      • 3.2.3.2. Increasing number of road accidents and injuries
      • 3.2.3.3. Expansion opportunity in post-surgical wound management
    • 3.2.4. Market Challenge Analysis
  • 3.3. U.S. Advanced Wound Care OTC Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal Landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological landscape

Chapter 4. U.S. Advanced Wound Care OTC Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Advanced Wound Care OTC Market Movement Analysis
  • 4.3. U.S. Advanced Wound Care OTC Market Size & Trend Analysis, by Product, 2021 - 2033 (USD Million)
  • 4.4. Foam Dressings
    • 4.4.1. Foam Dressings Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.2. Adhesive
      • 4.4.2.1. Adhesive Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.3. Non-adhesive Foam Dressings
      • 4.4.3.1. Non-adhesive Foam Dressings Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Film Dressings
    • 4.5.1. Film Dressings Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Hydrocolloids
    • 4.6.1. Hydrocolloids Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Hydrogel Dressings
    • 4.7.1. Hydrogel Dressings Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.8. Honey Dressings
    • 4.8.1. Honey Dressings Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.9. Greasy Gauzes
    • 4.9.1. Greasy Gauzes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.10. Non-Woven Post Operative Dressings
    • 4.10.1. Non-Woven Post Operative Dressings Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.11. Others
    • 4.11.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Advanced Wound Care OTC Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Advanced Wound Care OTC Market Movement Analysis
  • 5.3. U.S. Advanced Wound Care OTC Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 5.4. Chronic Wounds
    • 5.4.1. Chronic Wounds Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.4.2. Diabetic Foot Ulcers (Stage 1, Stage 2, Stage 3, Stage 4 and Deep Tissue Injury included)
      • 5.4.2.1. Diabetic Foot Ulcers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.4.3. Pressure Ulcers
      • 5.4.3.1. Pressure Ulcers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.4.4. Venous Leg Ulcers
      • 5.4.4.1. Venous Leg Ulcers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.4.5. Other Chronic Wounds
      • 5.4.5.1. Other Chronic Wounds Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Acute Wounds
    • 5.5.1. Acute Wounds Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.5.2. Surgical & Traumatic Wounds (skin tears included)
      • 5.5.2.1. Surgical & Traumatic Wounds (skin tears included) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.5.3. Burns
      • 5.5.3.1. Burns Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.5.3.2. 1st Degree Burns
        • 5.5.3.2.1. 1st Degree Burns Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.5.3.3. 2nd Degree Burns
        • 5.5.3.3.1. 2nd Degree Burns Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.5.3.4. 3rd Degree Burns
        • 5.5.3.4.1. 3rd Degree Burns Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. Advanced Wound Care OTC Market: Distribution Channel Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. Advanced Wound Care OTC Market Movement Analysis
  • 6.3. U.S. Advanced Wound Care OTC Market Size & Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Million)
  • 6.4. Retail Pharmacies / Drugstores
    • 6.4.1. Retail Pharmacies / Drugstores Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. E-commerce/Online Pharmacies / Health E-tailers
    • 6.5.1. E-commerce/Online Pharmacies / Health E-tailers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Others
    • 6.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Market Participant Categorization
  • 7.2. Key Company Profiles
  • 7.3. Company Share Analysis, 2024
    • 7.3.1. Smith+Nephew
      • 7.3.1.1. Company Overview
      • 7.3.1.2. Financial Performance
      • 7.3.1.3. Product Benchmarking
      • 7.3.1.4. Strategic Initiatives
    • 7.3.2. Solventum
      • 7.3.2.1. Company Overview
      • 7.3.2.2. Financial Performance
      • 7.3.2.3. Product Benchmarking
      • 7.3.2.4. Strategic Initiatives
    • 7.3.3. Molnlycke Health Care AB
      • 7.3.3.1. Company Overview
      • 7.3.3.2. Financial Performance
      • 7.3.3.3. Product Benchmarking
      • 7.3.3.4. Strategic Initiatives
    • 7.3.4. 3M
      • 7.3.4.1. Company Overview
      • 7.3.4.2. Financial Performance
      • 7.3.4.3. Product Benchmarking
      • 7.3.4.4. Strategic Initiatives
    • 7.3.5. Convatec Inc.
      • 7.3.5.1. Company Overview
      • 7.3.5.2. Financial Performance
      • 7.3.5.3. Product Benchmarking
      • 7.3.5.4. Strategic Initiatives
    • 7.3.6. Lavior
      • 7.3.6.1. Company Overview
      • 7.3.6.2. Financial Performance
      • 7.3.6.3. Product Benchmarking
      • 7.3.6.4. Strategic Initiatives
    • 7.3.7. Vomaris Innovations, Inc.
      • 7.3.7.1. Company Overview
      • 7.3.7.2. Financial Performance
      • 7.3.7.3. Product Benchmarking
      • 7.3.7.4. Strategic Initiatives
    • 7.3.8. B. Braun SE
      • 7.3.8.1. Company Overview
      • 7.3.8.2. Financial Performance
      • 7.3.8.3. Product Benchmarking
      • 7.3.8.4. Strategic Initiatives
    • 7.3.9. Coloplast Group
      • 7.3.9.1. Company Overview
      • 7.3.9.2. Financial Performance
      • 7.3.9.3. Product Benchmarking
      • 7.3.9.4. Strategic Initiatives
    • 7.3.10. PAUL HARTMANN AG
      • 7.3.10.1. Company Overview
      • 7.3.10.2. Financial Performance
      • 7.3.10.3. Product Benchmarking
      • 7.3.10.4. Strategic Initiatives
    • 7.3.11. Beiersdorf
      • 7.3.11.1. Company Overview
      • 7.3.11.2. Financial Performance
      • 7.3.11.3. Product Benchmarking
      • 7.3.11.4. Strategic Initiatives
    • 7.3.12. Dimora Medical
      • 7.3.12.1. Company Overview
      • 7.3.12.2. Financial Performance
      • 7.3.12.3. Product Benchmarking
      • 7.3.12.4. Strategic Initiatives
    • 7.3.13. Remedium Healthcare Products
      • 7.3.13.1. Company Overview
      • 7.3.13.2. Financial Performance
      • 7.3.13.3. Product Benchmarking
      • 7.3.13.4. Strategic Initiatives
    • 7.3.14. Sonoma Pharmaceuticals, Inc.
      • 7.3.14.1. Company Overview
      • 7.3.14.2. Financial Performance
      • 7.3.14.3. Product Benchmarking
      • 7.3.14.4. Strategic Initiatives
    • 7.3.15. Cardinal Health
      • 7.3.15.1. Company Overview
      • 7.3.15.2. Financial Performance
      • 7.3.15.3. Product Benchmarking
      • 7.3.15.4. Strategic Initiatives
    • 7.3.16. DeRoyal Industries, Inc.
      • 7.3.16.1. Company Overview
      • 7.3.16.2. Financial Performance
      • 7.3.16.3. Product Benchmarking
      • 7.3.16.4. Strategic Initiatives
    • 7.3.17. Medline Industries, LP
      • 7.3.17.1. Company Overview
      • 7.3.17.2. Financial Performance
      • 7.3.17.3. Product Benchmarking
      • 7.3.17.4. Strategic Initiatives
    • 7.3.18. Lavior
      • 7.3.18.1. Company Overview
      • 7.3.18.2. Financial Performance
      • 7.3.18.3. Product Benchmarking
      • 7.3.18.4. Strategic Initiatives

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. U.S. Advanced Wound Care OTC Market, by Product, 2021 - 2033 (USD Million)
  • Table 4. U.S. Advanced Wound Care OTC Market, by Application, 2021 - 2033 (USD Million)
  • Table 5. U.S. Advanced Wound Care OTC Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 6. Participant's Overview
  • Table 7. Financial Performance
  • Table 8. Product Benchmarking
  • Table 9. Strategic Initiatives

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 U.S. Advanced Wound Care OTC Market, Market Segmentation
  • Fig. 7 Market Driver Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Analysis (Current & Future Impact)
  • Fig. 9 Market Opportunity Analysis (Current & Future Impact)
  • Fig. 10 Market Challenge Analysis (Current & Future Impact)
  • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 Regional Marketplace: Key Takeaways
  • Fig. 14 U.S. Advanced Wound Care OTC Market, for Product, 2021 - 2033 (USD Million)
  • Fig. 15 U.S. Advanced Wound Care OTC Market, for Foam Dressings, 2021 - 2033 (USD Million)
  • Fig. 16 U.S. Advanced Wound Care OTC Market, for Adhesive, 2021 - 2033 (USD Million)
  • Fig. 17 U.S. Advanced Wound Care OTC Market, for Non-adhesive foam dressings, 2021 - 2033 (USD Million)
  • Fig. 18 U.S. Advanced Wound Care OTC Market, for Film Dressings, 2021 - 2033 (USD Million)
  • Fig. 19 U.S. Advanced Wound Care OTC Market, for Hydrocolloids, 2021 - 2033 (USD Million)
  • Fig. 20 U.S. Advanced Wound Care OTC Market, for Hydrogel Dressings, 2021 - 2033 (USD Million)
  • Fig. 21 U.S. Advanced Wound Care OTC Market, for Honey Dressings, 2021 - 2033 (USD Million)
  • Fig. 22 U.S. Advanced Wound Care OTC Market, for Greasy Gauzes, 2021 - 2033 (USD Million)
  • Fig. 23 U.S. Advanced Wound Care OTC Market, for Non-Woven Post Operative Dressings, 2021 - 2033 (USD Million)
  • Fig. 24 U.S. Advanced Wound Care OTC Market, for Others, 2021 - 2033 (USD Million)
  • Fig. 25 U.S. Advanced Wound Care OTC Market, for Application, 2021 - 2033 (USD Million)
  • Fig. 26 U.S. Advanced Wound Care OTC Market, for Chronic Wounds, 2021 - 2033 (USD Million)
  • Fig. 27 U.S. Advanced Wound Care OTC Market, for Diabetic Foot Ulcers, 2021 - 2033 (USD Million)
  • Fig. 28 U.S. Advanced Wound Care OTC Market, for Pressure Ulcers, 2021 - 2033 (USD Million)
  • Fig. 29 U.S. Advanced Wound Care OTC Market, for Venous Leg Ulcers, 2021 - 2033 (USD Million)
  • Fig. 30 U.S. Advanced Wound Care OTC Market, for Other Chronic Wounds, 2021 - 2033 (USD Million)
  • Fig. 31 U.S. Advanced Wound Care OTC Market, for Acute Wounds, 2021 - 2033 (USD Million)
  • Fig. 32 U.S. Advanced Wound Care OTC Market, for Surgical & Traumatic Wounds (skin tears included), 2021 - 2033 (USD Million)
  • Fig. 33 U.S. Advanced Wound Care OTC Market, for Burns, 2021 - 2033 (USD Million)
  • Fig. 34 U.S. Advanced Wound Care OTC Market, for 1st Degree Burns, 2021 - 2033 (USD Million)
  • Fig. 35 U.S. Advanced Wound Care OTC Market, for 2nd Degree Burns, 2021 - 2033 (USD Million)
  • Fig. 36 U.S. Advanced Wound Care OTC Market, for 3rd Degree Burns, 2021 - 2033 (USD Million)
  • Fig. 37 U.S. Advanced Wound Care OTC Market, for Distribution Channel, 2021 - 2033 (USD Million)
  • Fig. 38 U.S. Advanced Wound Care OTC Market, for Retail Pharmacies / Drugstores, 2021 - 2033 (USD Million)
  • Fig. 39 U.S. Advanced Wound Care OTC Market, for E-commerce/Online Pharmacies / Health E-tailers, 2021 - 2033 (USD Million)
  • Fig. 40 U.S. Advanced Wound Care OTC Market, for Others, 2021 - 2033 (USD Million)